The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential
Hiroyuki Mori, Ken Inoki, Kohsuke Masutani, Yu Wakabayashi, Kyoko Komai, Ryusuke Nakagawa, Kun-Liang Guan, Akihiko YoshimuraVolume:
384
Year:
2009
Language:
english
Pages:
476
DOI:
10.1016/j.bbrc.2009.04.136
File:
PDF, 845 KB
english, 2009